FDA moves to rehire medical device staffers fired only days earlier
The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, ...
Hosted on MSN29m
Former Top Drug Regulator Lands Cushy Pfizer Gig After Leaving FDA During Trump Transition
Patrizia Cavazzoni, the former director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, ...
Hims & Hers warns it may stop selling compounded weight-loss drugs
Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...
Adderall shortage continues to impact millions of Americans living with ADHD
ADHD Advisor examined data from the Drug Enforcement Administration and other sources to see why the Adderall shortage ...
These 3 healthcare stories are spooking investors. But they shouldn't worry.
Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.
Stocks to Watch: Hims & Hers Health, Chegg, Wah Fu Education Group
Hims & Hers Health beat fourth-quarter estimates and guided for better-than-expected revenue in the first quarter and 2025. The telehealth provider logged earnings of 11 cents a share on revenue of ...